EBS

EMERGENT BIOSOLUTIONS INC

Healthcare | Small Cap

$0.86

EPS Forecast

$182.1

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$0.86

Revenue Forecast:

$182.1

EPS Surprise Forecast:

-$0.010

Revenue Surprise Forecast:

-$4

Post-release price volatility - Very high

Post-release Overnight Move:

±11.8%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

48%

Probability of beating revenue consensus:

37%

Probability of beating both EPS & revs consensus:

23%

Probability of missing both EPS & revs consensus:

38%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-5

Beta (β)

Forward Looking Beta (β):

1.73

Earnings volatility

EPS standard deviation:

$0.30

Revenue standard deviation:

$26

As % of share price:

3.70% EXTREME UNCERTAINTY

As % of market cap:

6.24% VERY HIGH

Confidence intervals and percentiles

EPS 95th %ile:

$1.22

Revenue 95th %ile:

$213

EPS 75th %ile:

$0.96

Revenue 75th %ile:

$190

EPS 25th %ile:

$0.77

Revenue 25th %ile:

$175

EPS 5th %ile:

$0.50

Revenue 5th %ile:

$156

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

36% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

21% MEDIUM

Stock's bid-ask spread

Bid-ask per $10K:

$45

Bid-ask per Share:

$0.035